September 26, 2011 Infinitt North America said its Xelis Fusion software has received clearance from the U.S. Food and Drug Administration (FDA), and is now widely available to the North American market.  

The software can be used as an integrated solution with the company’s web-based picture archiving and communication system (PACS) or as a stand-alone solution; this allows any third-party PACS user to query, view and analyze studies from any DICOM database to do fusion of computed tomography (CT), positron emission tomography (PET) and magnetic resonance (MR) images. 

According to the company, the system has been in use at 12 institutions across the United States and has demonstrated the ability to improve diagnosis and enhance productivity.

The Xelis Fusion:

- Supports fusion of PET, CT and MR data in any combination

- Offers automatic and manual registration methods, quantitative analysis tools and rapid image navigation

- Supports 3-D region of interest (ROI) analysis

- Provides presets and layouts for comparing two image sets

- Calculates PET Standard Uptake Values (SUV)

- Offers multiple standard and user-defined color maps

- Stores/sends the fused images in DICOM 3.0 format

- Includes integrated, freely rotating MPR functions

PET/CT fusion is used primarily to assist in more accurate and reliable diagnosis of cancer, and is covered by most private insurance companies and Medicare. Co-registration and alignment of different scans showing the same patient and pathology can add value to numerous image-based clinical review processes.

Medicare is continually adding to its list of approved clinical indications for PET and PET-CT. Currently Medicare reimburses for PET and PET-CT for:

- Single pulmonary nodules

- Non small cell lung cancer

- Colorectal cancer

- Melanoma

- Lymphoma

- Head and neck cancer (excluding CNS and thyroid cancers)

- Esophageal cancer

- Breast cancer

- Cervical cancer

For more information: www.infinittna.com


 


Related Content

News | Artificial Intelligence

June 7, 2023 — Riverain Technologies, a medical device company revolutionizing chest imaging interpretation with Clear ...

Time June 07, 2023
arrow
News | Radiation Oncology

June 5, 2023 — Volpara Health Technologies Ltd. announces its founding membership in CancerX, a public-private ...

Time June 05, 2023
arrow
News | Enterprise Imaging

June 1, 2023 — aycan, a recognized worldwide leader in medical imaging, released aycan workstation 4.00 earlier this ...

Time June 01, 2023
arrow
Feature | Radiology Imaging | By Melinda Taschetta-Millane

It's been a fruitful month for itnonline.com! Here's a look at what ITN viewers found to be most interesting during the ...

Time June 01, 2023
arrow
News | Artificial Intelligence

May 31, 2023 — GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning ...

Time May 31, 2023
arrow
News | Radiation Oncology

May 31, 2023 — Elekta announced the launch of the first phase of Elekta ONE*, its most comprehensive and advanced ...

Time May 31, 2023
arrow
News | Radiology Business

May 26, 2023 — HIMSS has appointed two technology executives at the helm as chair and vice chair of the HIMSS Board of ...

Time May 26, 2023
arrow
News | Artificial Intelligence

May 24, 2023 — Since the launch of ChatGPT in November 2022, the use of large language models (LLMs) powered by ...

Time May 24, 2023
arrow
News | Radiology Business

May 23, 2023 — Intelerad Medical Systems, a leading global provider of enterprise medical imaging solutions, announced ...

Time May 23, 2023
arrow
News | Artificial Intelligence

May 19, 2023 — The latest version of ChatGPT passed a radiology board-style exam, highlighting the potential of large ...

Time May 19, 2023
arrow
Subscribe Now